Income Tax Expense (Benefit) of Regen BioPharma Inc from 30 Sep 2024 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Regen BioPharma Inc quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 30 Sep 2024 to 31 Dec 2025.
Regen BioPharma Inc Income Tax Expense (Benefit) for the quarter ending 31 Dec 2025 was $0.
Regen BioPharma Inc annual Income Tax Expense (Benefit) for 2025 was $0.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), Annual (USD)

Regen BioPharma Inc Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025		$0	$0		01 Oct 2025	31 Dec 2025	10-Q	13 Feb 2026	2026	Q1
Q4 2024		$0			01 Oct 2024	31 Dec 2024	10-Q	13 Feb 2026	2026	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$0	$0		01 Oct 2024	30 Sep 2025	10-K	30 Dec 2025	2025	FY
2024	$0			01 Oct 2023	30 Sep 2024	10-K	30 Dec 2025	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.